Per Samuelsson was appointed to the board of Oncopeptides in 2012.
Per is a partner at HealthCap, a life sciences venture capital business.
Per has over 15 years investment banking experience, mainly with Aros Securities based in Sweden. At Aros Securities he held several roles including being a Director in the corporate finance department where he specialized in merger transactions, initial public offerings and equity incentive programs. Per also held the role of Head of Research at Aros Securities.
Per holds an MSc in Engineering from the Institute of Technology in Linköping, Sweden.
Board Committees: Member of the Audit Committee and the Remuneration Committee
Holdings in Oncopeptides: -
Other current positions: Board Member of Cantando AB, Cantando Holding AB, HealthCap AB, HealthCap Annex Fund I-II GP AB, HealthCap Orx Holdings GP AB, HealthCap 1999 GP AB, HealthCap III Sidefund GP AB, Pretzel Therapeutics, Inc., SatoSea Oncology GmbH, Skipjack AB, SwedenBIO Service AB, Nordic Nanovector ASA and Targovax ASA.
Independent in relation to the Company and its senior management, but not in relation to major shareholders. Partner in HealthCap and holder of directorships in several companies within the HealthCap Group.